AIby Angela Guess
A new press release reports, “BioSymetrics, Inc., a technology company that aims to transform data analytics for the biomedical industry, today announced the launch of its pre-processing and analytics platform, Augusta. Augusta is a proprietary technology that allows standardized processing and integration of multiple, diverse raw data types, facilitating rapid deployment of AI projects in precision medicine, drug discovery, and health data applications. Currently, Augusta provides over 150 modules for the processing of raw genomic, metabolomic, MRI/fMRI, chemical, ECG/EEG, and EMR data, and subsequent analysis, all controlled through an automated optimization framework.”
BioSymetrics’ Chief Scientific Officer, Gabriel Musso, said about Augusta, “When you work in Data Science, specifically in the health space, the major hurdles in analyzing data are not technological, they’re practical. We’ve seen this in our own work when developing diagnostic models for Autism and Alzheimer’s Disease, and were astonished at how much of our time was spent processing MRIs and other medical data before analytic projects could begin. We’ve sought to address this need by designing an easily deployable, automated pre-processing framework that can take multiple data types from source, process them, integrate them, and apply machine learning, all in a data-driven way.”
Read more at Business Wire.
Photo credit: BioSymetrics